Bellevue Life Sciences Acquisition Corp (BLAC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bellevue Life Sciences Acquisition Corp  (NASDAQ: BLAC)


Bellevue Life Sciences Acquisition's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bellevue Life Sciences Acquisition's ROI in the second quarter of 2026?
Bellevue Life Sciences Acquisition Corp recorded a cumulative net loss of $-15 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -7.7%.

Within the Healthcare sector 90 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3040, from total ROI ranking in the first quarter of 2026 at 3583.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 68.54 % 232.99 % 1254 % 155.13 % 90.6 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 172 180 207 217 228
Return On Investment (TTM) -7.7 % -9.21 % -12.43 % -13.37 % -16.45 %
BLAC's Overall Ranking # 3040 # 3583 # 3265 # 3386 # 3497
Seq. Investment Change TTM -6.74 % -4.56 % 31.97 % 43.49 % 84.26 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -15 -19 -27 -22 -19

BLAC Company Profile >> Back to BLAC Roi Comparisons >> See Annual BLAC Return On Investment



Return On Investment BLAC's Ranking
Within: No.
Industry # 27
Sector # 91
Overall # 3040

Return On Investment Statistics
High Average Low
2.7 %
-8.36 %
-22.07 %
  (Mar 31 2025)







Financial Statements
Bellevue Life Sciences Acquisition's II. Quarter Investments $ 172 Millions BLAC's Balance sheet
Bellevue Life Sciences Acquisition's II. Quarter Income $ -1 Millions Quarterly BLAC's Income Statement
BLAC's Income by Division See BLAC's Income by Division


BLAC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022
Total Investments in Millions 203 -4 190 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -27 -2 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -13.3 % - 0.21 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BLAC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BLAC's Competitors
Subscribers only: Roi for Bellevue Life Sciences Acquisition's Suppliers
Subscribers only: Return On Investment for BLAC's Customers

Other Ratios
BLAC's Roa BLAC's Inventory Turnover Ratio BLAC's Growth Rates BLAC's Dividend Statistics
BLAC's Profitability Ratios BLAC's Asset Turnover Ratio BLAC's Dividend Growth
BLAC's Roe BLAC's Valuation Ratios BLAC's Financial Strength Ratios BLAC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-08-17T17:21:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.